Private Advisor Group, LLC Esperion Therapeutics, Inc. Transaction History
Private Advisor Group, LLC
- $18.8 Billion
- Q3 2025
A detailed history of Private Advisor Group, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 53,606 shares of ESPR stock, worth $155,457. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,606
Previous 40,106
33.66%
Holding current value
$155,457
Previous $39,000
264.1%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ESPR
# of Institutions
214Shares Held
114MCall Options Held
643KPut Options Held
769K-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.1 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.75MShares$28.3 Million0.51% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...